Requirement for PI 3-kinase γ in macrophage migration to MCP-1 and CSF-1

Phosphoinositide 3-kinases (PI3Ks) are important regulators of cell migration. The PI3K isoform γ is primarily expressed in haematopoietic cells, and is activated by G protein-coupled receptors (GPCRs). Here, we investigate the contribution of PI3Kγ to macrophage responses to chemoattractants, using...

Full description

Saved in:
Bibliographic Details
Published inExperimental cell research Vol. 290; no. 1; pp. 120 - 131
Main Authors Jones, Gareth E., Prigmore, Elena, Calvez, Ronan, Hogan, Catherine, Dunn, Graham A., Hirsch, Emilio, Wymann, Matthias P., Ridley, Anne J.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 15.10.2003
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Phosphoinositide 3-kinases (PI3Ks) are important regulators of cell migration. The PI3K isoform γ is primarily expressed in haematopoietic cells, and is activated by G protein-coupled receptors (GPCRs). Here, we investigate the contribution of PI3Kγ to macrophage responses to chemoattractants, using bone marrow-derived macrophages from wild-type and PI3Kγ-null mice. We observe that early membrane ruffling induced by MCP-1, which activates a GPCR, or by CSF-1, which activates a tyrosine kinase receptor, is unaltered in PI3Kγ −/− mice, although by 30 min MCP-1-induced cell polarization was strongly reduced in PI3Kγ −/− compared to wild-type macrophages. The migration behaviour of the macrophages was analysed by time-lapse microscopy in Dunn chemotaxis chambers. PI3Kγ −/− macrophages showed reduced migration speed and translocation, and no chemotaxis to MCP-1. Interestingly, there was also a reduction in migration efficiency in PI3Kγ −/− macrophages stimulated with CSF-1 although early CSF-1R signalling was normal. These results indicate that the initial actin reorganization induced by either a GPCR or tyrosine kinase receptor agonist is not dependent on PI3Kγ, whereas PI3Kγ is needed for optimal migration of macrophages to either agonist.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0014-4827
1090-2422
DOI:10.1016/S0014-4827(03)00318-5